📰 Alimera Sciences News
Alimera Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alimera Sciences. Real-time updates on events, politics, business and more.
June 1, 2024
Alimera Sciences, Inc. (NASDAQ:ALIM – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 103,900 shares, a decline of 14.6% from the April 30th total of 121,700 shares. Based on an average daily trading volume, of 67,700 […]
May 27, 2024
AIGH Capital Management LLC lowered its stake in shares of Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,226,068 shares of the biopharmaceutical company’s stock after selling 146,504 […]
May 19, 2024
Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) – HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter, down from their prior forecast […]
May 16, 2024
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The
May 4, 2024
StockNews.com lowered shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning. Separately, Maxim Group assumed coverage on Alimera Sciences in a report on Monday, March 25th. They set a buy rating and a $10.00 target price on the stock. View Our […]
May 4, 2024
StockNews.com downgraded shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Maxim Group started coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a buy rating and a $10.00 price […]
April 23, 2024
Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a “buy” rating and a $10.00 price target […]
April 23, 2024
Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a report on Monday, March 25th. They set a “buy” rating and a $10.00 […]
April 13, 2024
Alimera Sciences (NASDAQ:ALIM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Separately, Maxim Group initiated coverage on Alimera Sciences in a research note on Monday, March 25th. They set a “buy” rating and a $10.00 price objective on the […]
April 2, 2024
/PRNewswire/ -- Luckie & Company announces the acquisition of Marbury Creative Group (MCG), an Atlanta-based creative marketing agency recognized for its work...